NCT03821155

Brief Summary

To investigate which treatment option (corticosteroid treatment alone or combined corticosteroid treatment and vestibular rehabilitation) is the most effective in patients diagnosed with vestibular neuritis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 21, 2019

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 29, 2019

Completed
3 days until next milestone

Study Start

First participant enrolled

February 1, 2019

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2021

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2022

Completed
Last Updated

July 29, 2022

Status Verified

July 1, 2022

Enrollment Period

2.4 years

First QC Date

January 21, 2019

Last Update Submit

July 28, 2022

Conditions

Keywords

Vestibular NeuritisSHIMP (suppressing head impulse paradigm)SVV (subjective visual vertical)Vestibular rehabilitationPrednisolonev-HIT (video head impulse test)Vestibular Neuronitis

Outcome Measures

Primary Outcomes (4)

  • Suppressing head impulse paradigm (SHIMP)

    SHIMP equipment will objectively quantify change of vestibular function.

    6 month

  • Subjective visual vertical (SVV)

    SVV test will objectively quantify the experienced spatial orientation as an indicator of visual and vestibular otolithic function

    6 month

  • Video head impulse test (v-HIT)

    v-HIT equipment will objectively quantify change of vestibular function.

    6 month

  • Dizziness handicap inventory (DHI) questionnaire

    Fulfillment of the questionnaire "Dizziness Handicap Inventory" (DHI) will quantify the level of experienced vertigo.

    6 month

Study Arms (2)

Neuritis vestibularis (group 1)

ACTIVE COMPARATOR

Corticosteroid ("prednisolone")

Drug: Corticosteroid

Neuritis vestibularis (group 2)

EXPERIMENTAL

Corticosteroid ("prednisolone") + vestibular rehabilitation

Other: Vestibular rehabilitationDrug: Corticosteroid

Interventions

Specialized physical therapy aimed at restoring balance

Neuritis vestibularis (group 2)

Prednisolone

Neuritis vestibularis (group 1)Neuritis vestibularis (group 2)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age above 18 years of age
  • Medical history compatible with vestibular neuritis
  • Verification of vestibular neuritis with positive romberg test, pathological v-HIT and horizontal nystagmus with a rotatory component.

You may not qualify if:

  • Former medical history with vestibular dysfunction
  • Medical history or objective signs of cochlear dysfunction before, during or after onset of vestibular neuritis
  • Onset of symptoms 14 days before recruitment to the study
  • Focal neurological symptoms/signs
  • Contraindication to prednisolone treatment
  • Problem with participating in vestibular rehabilitation due to muscular-skeletal disease ect.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Otolaryngology, Head & Neck Surgery and Audiology

Aalborg, North Denmark, 9000, Denmark

Location

MeSH Terms

Conditions

Vestibular Neuronitis

Interventions

Adrenal Cortex Hormones

Condition Hierarchy (Ancestors)

Vestibulocochlear Nerve DiseasesRetrocochlear DiseasesEar DiseasesOtorhinolaryngologic DiseasesCranial Nerve DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

HormonesHormones, Hormone Substitutes, and Hormone Antagonists

Study Officials

  • Dan D Hougaard, MD

    Aalborg University Hospital

    PRINCIPAL INVESTIGATOR
  • Martin H Wolder, MS

    Aalborg University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Patients randomized to two different treatments: 1. corticosteroid treatment ("prednisolone") 2. combined corticosteroid treatment ("prednisolone") and vestibular rehabilitation
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, Assistant Professor

Study Record Dates

First Submitted

January 21, 2019

First Posted

January 29, 2019

Study Start

February 1, 2019

Primary Completion

July 1, 2021

Study Completion

January 1, 2022

Last Updated

July 29, 2022

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will not share

Locations